Lillian Y Shiiba, MPAS, PA-C
Physician Assistant · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lillian Y Shiiba’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C14676 · Cancelled
Licence status: Cancelled · since 1953 · Indiana University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$5,943
Pharmacies billed $5,943 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 62) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
50 generic and 12 brand-name prescriptions · $5,943 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 12 | $5,042 | $420 |
| Tamsulosin | 27 | $610 | $23 |
| Finasteride | 15 | $122 | $8 |
Year by year
| 2024 | 62 | 32 | 0% (0) | 19% | $5,943 |
| 2023 | 404 | 181 | None | None | $29,852 |
| 2022 | 424 | 182 | None | None | $23,361 |
| 2021 | 530 | 205 | None | None | $27,010 |
| 2020 | 639 | 229 | None | None | $30,126 |
| 2019 | 370 | 179 | 3% (12) | 8% | $26,286 |
| 2018 | 510 | 184 | None | 7% | $27,838 |
| 2017 | 509 | 163 | None | 5% | $22,303 |
| 2016 | 524 | 145 | 3% (14) | 9% | $29,357 |
| 2015 | 654 | 161 | 2% (13) | None | $28,202 |
| 2014 | 460 | 133 | 4% (18) | None | $15,438 |
| 2013 | 371 | 92 | None | 16% | $22,957 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Myrbetriq | 24 | $17,607 | $734 |
| Tamsulosin | 147 | $4,245 | $29 |
| Finasteride | 74 | $1,679 | $23 |
| Alfuzosin Hcl Er | 21 | $1,316 | $63 |
| Nitrofurantoin Mono-Macro | 18 | $267 | $15 |
| Amoxicillin-Clavulanate Potass | 20 | $185 | $9 |
2022: 4 drugs
| Myrbetriq | 17 | $9,447 | $556 |
| Tamsulosin | 148 | $2,980 | $20 |
| Finasteride | 105 | $1,747 | $17 |
| Alfuzosin Hcl Er | 11 | $526 | $48 |
2021: 8 drugs
| Myrbetriq | 25 | $11,068 | $443 |
| Tamsulosin | 186 | $4,816 | $26 |
| Finasteride | 136 | $3,331 | $24 |
| Enoxaparin | 11 | $2,243 | $204 |
| Oxybutynin Chloride Er | 25 | $692 | $28 |
| Nitrofurantoin Mono-Macro | 13 | $355 | $27 |
| Oxybutynin Chloride | 14 | $331 | $24 |
| Alfuzosin Hcl Er | 12 | $300 | $25 |
2020: 8 drugs
| Myrbetriq | 17 | $9,285 | $546 |
| Tamsulosin | 257 | $6,580 | $26 |
| Finasteride | 167 | $3,583 | $21 |
| Dutasteride | 19 | $1,512 | $80 |
| Oxybutynin Chloride Er | 15 | $940 | $63 |
| Terazosin | 21 | $563 | $27 |
| Amoxicillin-Clavulanate Potass | 13 | $146 | $11 |
| Ciprofloxacin | 14 | $57 | $4 |
2019: 5 drugs
| Myrbetriq | 11 | $10,693 | $972 |
| Tamsulosin | 134 | $3,424 | $26 |
| Finasteride | 97 | $2,700 | $28 |
| Enoxaparin | 11 | $1,833 | $167 |
| Oxybutynin Chloride Er | 19 | $989 | $52 |
2018: 5 drugs
| Tamsulosin | 242 | $5,965 | $25 |
| Finasteride | 102 | $2,762 | $27 |
| Enoxaparin | 12 | $1,968 | $164 |
| Oxybutynin Chloride Er | 32 | $1,633 | $51 |
| Ciprofloxacin | 12 | $84 | $7 |
2017: 6 drugs
| Tamsulosin | 201 | $4,860 | $24 |
| Myrbetriq | 12 | $3,868 | $322 |
| Oxybutynin Chloride Er | 69 | $2,414 | $35 |
| Enoxaparin | 11 | $1,905 | $173 |
| Finasteride | 96 | $1,828 | $19 |
| Ciprofloxacin | 23 | $160 | $7 |
2016: 7 drugs
| Tamsulosin | 202 | $5,654 | $28 |
| Myrbetriq | 15 | $4,445 | $296 |
| Tolterodine Tartrate Er | 14 | $4,254 | $304 |
| Oxybutynin Chloride Er | 65 | $2,292 | $35 |
| Dutasteride | 16 | $2,103 | $131 |
| Finasteride | 74 | $1,317 | $18 |
| Ciprofloxacin | 14 | $144 | $10 |
2015: 9 drugs
| Tamsulosin | 276 | $8,098 | $29 |
| Tolterodine Tartrate Er | 21 | $3,666 | $175 |
| Cialis | 11 | $2,281 | $207 |
| Finasteride | 139 | $2,018 | $15 |
| Oxybutynin Chloride Er | 27 | $1,228 | $45 |
| Alfuzosin Hcl Er | 22 | $210 | $10 |
| Bicalutamide | 11 | $175 | $16 |
| Ciprofloxacin | 20 | $128 | $6 |
| Terazosin | 23 | $116 | $5 |
2014: 8 drugs
| Tamsulosin | 152 | $2,785 | $18 |
| Avodart | 13 | $2,092 | $161 |
| Oxybutynin Chloride Er | 35 | $1,982 | $57 |
| Finasteride | 104 | $1,515 | $15 |
| Potassium Citrate Er | 11 | $1,292 | $117 |
| Bicalutamide | 17 | $971 | $57 |
| Hydrocodone-Acetaminophen | 13 | $122 | $9 |
| Sulfamethoxazole-Trimethoprim | 12 | $112 | $9 |
2013: 7 drugs
| Avodart | 22 | $3,795 | $173 |
| Tamsulosin | 116 | $2,686 | $23 |
| Finasteride | 68 | $1,636 | $24 |
| Oxybutynin Chloride Er | 21 | $1,529 | $73 |
| Bicalutamide | 15 | $957 | $64 |
| Alfuzosin | 12 | $233 | $19 |
| Terazosin | 14 | $160 | $11 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689691685
- Licence
- CA 14676California C14676: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-16
- NPI last updated
- 2023-04-07
- NPI record certified
- 2023-04-07
This is when the NPI record was last certified, not a medical board exam.